SYS-CON MEDIA Authors: Lori MacVittie, Gilad Parann-Nissany, Unitiv Blog, Bob Gourley, Kevin Benedict

News Feed Item

Services Sector Reports November 2013 Sales and Joint Ventures - Research Report on Walgreen, Cardinal Health, Macy's, Rite Aid, and GNC

Editor Note: For more information about this release, please scroll to bottom.

NEW YORK, December 17, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Walgreen Co. (NYSE: WAG), Cardinal Health, Inc. (NYSE: CAH), Macy's, Inc. (NYSE: M), Rite Aid Corp. (NYSE: RAD), and GNC Holdings Inc. (NYSE: GNC). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Walgreen Co. Research Report

On December 4, 2013, Walgreen Co. (Walgreens) reported its sales for the month of November 2013 with sales increasing 4.1% YoY to $6.1 billion. Walgreens' prescriptions filled at comparable stores increased by 1.4% YoY in November 2013 - which were positively impacted by 0.4 percentage point due to more flu shots but were negatively impacted by 0.7 percentage point due to the slowest start to the flu season in six years. The Company further informed that November 2013 pharmacy sales increased by 4.7%, while comparable store pharmacy sales increased 4.0%. Walgreens' total sales for the Q1 FY 2014, which ended November 30, 2013, were c.$18.4 billion, up 6.0% YoY. Comparable store sales for the Q1 FY 2014 increased 5.5% while front-end comparable store sales for Q1 FY 2014 increased 2.2%, and prescriptions filled at comparable stores increased 5.6% while comparable pharmacy sales increased 7.5% in Q1 FY 2014. The Full Research Report on Walgreen Co. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/844c_WAG

--

Cardinal Health, Inc. Research Report

On December 10, 2013, Cardinal Health, Inc. (Cardinal Health), along with CVS Caremark (CVS), announced the signing of an agreement to form the largest generic sourcing entity in the US, which is the world's largest generic drug market. According to the release, both the Companies will contribute their sourcing and supply chain expertise to this 50/50 joint venture and are committing to source generic drugs through it. The two Companies have separately announced a three-year extension through June 2019 of Cardinal Health's existing pharmaceutical distribution agreements with CVS Caremark. The Company reported that the US-based joint venture is expected to be operational as soon as July 1, 2014, with an initial term of 10 years, which will source and negotiate generic supply contracts for both the Companies. The Company informed that in order to reflect an equitable 50/50 joint venture, the agreement includes a quarterly payment of $25 million over the life of the agreement from Cardinal Health to CVS Caremark. Cardinal Health also reported that the  said payments have an estimated after-tax present value of $435 million. The Full Research Report on Cardinal Health, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/ee30_CAH

--

Macy's, Inc. Research Report

On December 5, 2013, Macy's, Inc. (Macy's) announced that it has signed a multi-year agreement for an exclusive new women's fashion brand inspired by Thalía, who is an internationally recognized actor, recording artist, music producer, author and philanthropist. The Company reported that the new brand is called Thalía Sodi and is expected to launch exclusively in 300 Macy's stores nationwide and on macys.com in spring 2015 with dresses, tops, pants, shoes and jewelry. Chairman, President and CEO Terry J. Lundgren said, "When it comes to fashion, Thalía is a trendsetter for Latinas who love to step out and stand out in a way that is flirty, fun, vivacious and put together. Hispanic women are one of the fastest-growing consumer segments in America and already important customers for Macy's in major markets across the country. With this new Thalía Sodi brand, sold only at Macy's, we will have an even stronger fashion offering that directly addresses the style, fit, and color preferences of this customer." The Full Research Report on Macy's, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/b69d_M

--

Rite Aid Corp. Research Report

On December 5, 2013, Rite Aid Corp. (Rite Aid) reported same store sales for November 2013 (five-week period ended November 30, 2013). Rite Aid reported that same store sales increased 2.8% YoY. According to Rite Aid, November 2013 front-end same store sales increased 0.4% YoY and pharmacy same store sales increased 3.9% YoY, which included an approximate 81 basis points negative impact from new generic introductions. The Company also informed that prescription count at comparable stores increased 0.1% YoY. Rite Aid's total drugstore sales for the five-week period increased 1.6% YoY to c.$2.4 billion, and prescription sales accounted for 68.1% of drugstore sales, while third party prescription sales represented 97.1% of pharmacy sales. The Full Research Report on Rite Aid Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/f64e_RAD

--

GNC Holdings Inc. Research Report

On December 11, 2013, GNC Holdings Inc. (GNC) announced that the Company awards $100,000 in prizes in "ME ON GNC" contest. GNC reported that under this contest, winners tell their own "Respect Yourself" stories in photos and videos that document their success in losing weight and achieving health & wellness goals. The Company informed that the three top winners in each category, whose stories can be seen on the "ME ON GNC" Contest webpage, will share $100,000 in prizes, with the two top prizewinners receiving $25,000 each. The Full Research Report on GNC Holdings Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/54b0_GNC

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
  5. For any urgent concerns or inquiries, please contact us at [email protected].
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsCorner.com

SOURCE Analysts' Corner

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.